AMIODARONE HYDROCHLORIDE INJECTION
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency awarded contract SPE2D226F3428 to DMS Pharmaceutical Group Inc on September 8, 2026, for the procurement of Amiodarone Hydrochloride Injection. This specific delivery order, valued at 33.56 dollars for one package, was issued under the broader base administrative contract SPE2DX25D9822, which carries a total award value of 20,000,000.00 dollars. The order is managed by the Department of Defense through the DLA Troop Support Medical Supply Chain. Key requirements for this delivery include a delivery date of September 8, 2026, with inspection and acceptance occurring at the destination. The procurement is categorized under the federal organization type and follows the standard commercial item solicitation and award processes.
General Info
Contract Value
$33.56Place of Performance
Not specifiedSet-Aside
Awardee
DMS PHARMACEUTICAL GROUP INCAward Issued Date
Documents
2AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Earlier notices in this NAICS code
Posted before this notice, open and closed
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
